A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett’s esophagus patients after extended follow up; results from Dutch surveillance cohorts.

por Hoefnagel, S. J. M., Mostafavi, N., Timmer, M. R., Lau, C. T., Meijer, S. L., Wang, K. K., Krishnadath, K. K.
Publicado 2020

The Y-chromosome F haplogroup contributes to the development of Barrett’s esophagus-associated esophageal adenocarcinoma in a white male population

por Westra, W M, Rygiel, A M, Mostafavi, N, de Wit, G M J, Roes, A L, Moons, L M G, Peppelenbosch, M P, Ouburg, S, Morré, S A, Jacobs, M, Siersema, P D, Repping, S, Wang, K K, Krishnadath, K K
Publicado 2020

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic...

por de Wit, K, Schaapman, J J, Nevens, F, Verbeek, J, Coenen, S, Cuperus, F J C, Kramer, M, Tjwa, E T T L, Mostafavi, N, Dijkgraaf, M G W, van Delden, O M, Beuers, U H W, Coenraad, M J, Takkenberg, R B
Publicado 2020